Table S2.
Pharmacokinetic parameters | C-DMSA | C-DMSA@VES-g-CSO/VES-g-CS MM |
---|---|---|
t1/2α (h) | 0.12±0.01 | 0.74±0.12** |
t1/2β (h) | 1.91±0.20 | 15.23±1.20** |
Vd (L/kg) | 0.21±0.06 | 0.17±0.04 |
AUC0-24h (μg·h/L) | 9.96±0.26 | 45.59±1.37*** |
CL (L/h/kg) | 0.49±0.07 | 0.10±0.02** |
Notes: All the rats were received the single dosage at an equivalent dose of C-DMSA (10 mg/kg). **p<0.01, ***p<0.001, compared to C-DMSA group. Data were presented as mean±SD (n=3).
Abbreviations: t1/2α, a rapid distribution half-life; t1/2β, elimination half-life; AUC, the area under the concentration-time curve; Vd, the apparent volume of the central chamber; CL, clearance; C-DMSA, 3-formyl-7-diethylamino coumarin masked meso-dimercaptosuccinic acid; C-DMSA@VES-g-CSO/VES-g-CS MM, C-DMSA loaded vitamin E succinate-grafted-chitosan oligosaccharide/vitamin E succinate-grafted-chitosan mixed micelles.